Wednesday, July 8, 2026

pharma · Acute Myeloid Leukemia · Breast Cancer

First People's Hospital

First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce

SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
SAN DIEGO, CA, CN
Programs
1136
Drugs
626
Patents
123
Clinical program

6-month course of antiandrogen drugs

Phase 3 · small molecule · Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

6-month course of antiandrogen drugs for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) is a Phase 3 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Internal code 2023-SR-258

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
The First People's Hospital of Lianyungang
Phase
Phase 3
Modality
small_molecule
Indication
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Status
active
Trials
1